Nabumetone
Who holds supplier records for Nabumetone? 7 organisations hold a current record for Nabumetone: an active US FDA Type II Drug Master File or a CEP. A further 11 organisations have only historical (inactive) DMF filings. 3 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (4), Netherlands (1), Italy (1) and China (1).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Nabumetone: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/nabumetone
Reading the evidence
- 7 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 4 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (7)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Nabumetone. Country is the organisation's recorded country, not necessarily the manufacturing site.
- Divis LaboratoriesIndiaCEP Company GMP cert on recordActive DMF 15364 · latest filing Apr 2001
- TAPI NL BVNetherlandsCEPActive DMF 22258 · latest filing Dec 2008
- ERREGIERRE SPAItaly Company GMP cert on recordActive DMF 14600, 19243 · latest filing Mar 2006
- Hetero Drugs LimitedIndia Company GMP cert on recordActive DMF 26747 · latest filing Dec 2012
- MATRIX PHARMACORP PRIVATE LTDIndiaActive DMF 18212 · latest filing Mar 2005
- SOUTHWEST SYNTHETIC PHARMACEUTICAL CORP LTDChinaActive DMF 18581 · latest filing Jun 2005
- Ipca Laboratories LimitedIndiaCEP Company GMP cert on recordInactive DMF 20620, 17566 · latest filing Jul 2007
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (3)
Certificates of Suitability on the EDQM register for Nabumetone, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 5 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| TAPI NL B.V. Amsterdam | NL | CEP 2000-115 - Rev 13 Nabumetone | Mar 2025 | — |
| DIVI'S LABORATORIES LIMITED Hyderabad | IN | R1-CEP 1999-055 - Rev 06 Nabumetone | Aug 2018 | — |
| IPCA Laboratories Limited Mumbai | IN | R1-CEP 2004-078 - Rev 02 Nabumetone | Feb 2017 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (11)
Organisations whose Type II DMFs for Nabumetone are no longer active. These show a past filing, not current supply.
Show all 11 historical records
- India · Inactive DMF 21467 · filed Mar 2008
- JIANGSU ZHONGDAN PHARMACEUTICAL CO LTDInactive DMF 18976 · filed Apr 2007
- Italy · Inactive DMF 15491 · filed Jun 2001
- Zhejiang Shenzhou Pharmaceutical Co., Ltd.China · Inactive DMF 14804 · filed Mar 2000
- API CORPInactive DMF 14174 · filed Jun 1999
- Italy · Inactive DMF 13105 · filed Jul 1998
- PHARMACEUTICAL FINE CHEMICALS PFC BAHAMAS LTDInactive DMF 12623 · filed Aug 1997
- United States · Inactive DMF 12445 · filed Mar 1997
- Italy · Inactive DMF 12296 · filed Dec 1996
- DINAMITE DIPHARMA SPAInactive DMF 12091 · filed Aug 1996
- ESTEVE QUIMICA SAInactive DMF 11984 · filed Jun 1996
Overview
Nabumetone is a non-steroidal anti-inflammatory drug (NSAID) used to treat pain and inflammation associated with conditions like arthritis. It is a prodrug that is metabolized in the liver to its active form, 6-methoxy-2-naphthylacetic acid (6MNA).
Chemical identity
- IUPAC name
- 4-(6-methoxynaphthalen-2-yl)butan-2-one
- Canonical SMILES
- CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC
- InChIKey
- BLXXJMDCKKHMKV-UHFFFAOYSA-N
- Synonyms
- Relafen API, brl-14777, nsc-758623, relafen
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Nonsteroidal Anti-inflammatory Drug
- Mechanism of action
- Cyclooxygenase Inhibitors
- Chemical structure
- Non-Steroidal
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Nabumetone?
7 organisations hold an active US FDA Type II Drug Master File or a CEP for Nabumetone: Divis Laboratories (India), TAPI NL BV (Netherlands), ERREGIERRE SPA (Italy), Hetero Drugs Limited (India), MATRIX PHARMACORP PRIVATE LTD (India), SOUTHWEST SYNTHETIC PHARMACEUTICAL CORP LTD (China) and Ipca Laboratories Limited (India). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Nabumetone Drug Master Files are active?
Divis Laboratories (DMF 15364), TAPI NL BV (DMF 22258), ERREGIERRE SPA (DMF 14600, 19243), Hetero Drugs Limited (DMF 26747), MATRIX PHARMACORP PRIVATE LTD (DMF 18212) and SOUTHWEST SYNTHETIC PHARMACEUTICAL CORP LTD (DMF 18581). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Nabumetone records mean?
11 organisations have only inactive Type II DMFs for Nabumetone. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Nabumetone have a European Certificate of Suitability?
Yes. 3 organisations hold a valid CEP for Nabumetone on the EDQM register, including TAPI NL B.V. Amsterdam (NL), DIVI'S LABORATORIES LIMITED Hyderabad (IN) and IPCA Laboratories Limited Mumbai (IN). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Nabumetone supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Nabumetone?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.